DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants

Core Viewpoint - DiagnaMed Holdings Corp. has issued 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to its directors, officers, and consultants as part of its equity incentive plan to align leadership interests with shareholders and reward contributions to the company's growth [1][2]. Group 1: Issuance Details - The stock options have an exercise price of $0.05 per share and are exercisable for three years from the date of grant [3]. - All RSUs and options are subject to the terms of the company's equity incentive plan and applicable regulatory approvals [3]. Group 2: Strategic Direction - The grants reflect the Board's confidence in the strategic direction of the company, particularly in advancing its natural hydrogen projects in Ontario with partners INRS and QIMC [4]. - DiagnaMed is committed to driving innovation and growth in the natural hydrogen sector in Ontario [4]. Group 3: Operational Initiatives - The company continues to advance its hydrogen development initiatives and enhance operational execution, strategically scaling its platform to capitalize on growth opportunities in the expanding natural hydrogen sector [5]. - This includes the ongoing deployment of the QIMC and INRS teams in Northern Ontario [5]. Group 4: Company Overview - DiagnaMed Holdings Corp. specializes in advanced hydrogen extraction technologies aimed at supporting the growing natural hydrogen industry, focusing on commercial scalability and delivering cost-effective, sustainable hydrogen solutions [6].